EFSH

1847 Holdings

EFSH

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about EFSH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Apr 4

$EFSH is at risk of delisting, with some posters speculating that the company is intentionally delaying its delisting to create a pump.
The potential delist pump could lead to a significant price increase, with some posters warning that shorts will struggle to cover their positions in the low-liquidity OTC market.
The company's move to the OTC market is seen as a positive development by some posters, who believe it will allow the company to regain its listing and potentially create a new catalyst for growth.

Generated by AI

Sentiment

Of the messages about EFSH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	19.12% -49.23
Bearish	—	—	—	80.88% +49.23

Bullish· Feb 14

$EFSH has a small float of 16M, big cash of $27M, and is expected to pump to $1.
The 13g filing by L1 Capital, a frequent participant in large pumps, is a strong indication that $EFSH is about to be mega pumped.
$EFSH has reported strong revenue growth and profitability for fiscal year 2023 and nine months ended September 30, 2024, with a big cash balance of $27M.

Bearish· Apr 3

The company has a history of providing inaccurate financials and making up numbers to suit their goals.
The company's management team is accused of being "seasoned, professional con men" who have engaged in a "scheme" to deceive investors.
The stock is likely to be delisted due to its low price, and the company may be obligated to repay its debts immediately, which it cannot afford.

Generated by AI

Topics

Of the messages about EFSH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	1.25%
Announcements	—	—	—	33.75%
Controversies	—	—	—	65%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Announcements· Sep 1

Novo Nordisk is set to acquire Forma Therapeutics, expanding its presence in sickle cell disease and rare blood disorders.
The acquisition aims to enhance Novo Nordisk's capabilities in these areas, with potential implications for the company's future growth and market position.
The deal is expected to have a significant impact on the rare blood disorder treatment market, with Novo Nordisk poised to become a major player in this space.

Technical Analysis· Nov 22

$EFSH has been oversold on the 4HR chart, with a history of rebounding on a multiplier, and has strong sales growth, good margins, and positive FCF.
The stock has bullish indicators on the hourly chart, including tape/flow and 20D/50D MA/MACD, and has huge gaps to fill, with buyers detected all over the hourly indicators.
The TTM squeeze indicator shows that the climb up is just getting started, with a predicted slow upward trend leading to a major blast off, and a potential run up to $0.50 or higher.

Generated by AI

Community

Of the messages about EFSH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	24.45%
Newcomers	—	—	—	75.55%

Regulars· Sep 1

The company's short volume is 52.89% of its total volume, indicating significant bearish sentiment among investors.
The regulars are focused on the company's undervaluation, with one user arguing that the stock price should be $40 based on its revenue and float.
Another regular is concerned about the potential for naked shorting and the company's decision to do a reverse split, which they see as a way for the CEO and management to benefit at the expense of shareholders.

Newcomers· Sep 1

The 1-for-25 reverse stock split announced by 1847 Holdings LLC has sparked concerns about potential dilution and the company's intentions, with some speculating about the motivations behind the move.
Some users are calling for a tender offer to take shares away from alleged "abusers" and increase demand, while others believe the split will lead to a significant increase in share price.
There is concern about the potential for the stock price to drop significantly before the reverse split takes effect, and some users are warning about the risks of shorting the stock, citing the company's history of dilution and alleged crookedness towards shareholders.

Generated by AI

Also Discussed

Investors talking about EFSH also mention

#	Name	Attention
1	LUXH - LuxUrban Hotels Inc.	——
2	Chanson International Holding Class A Ordinary SharesCHSN	0%0
3	BSFC - Blue Star Foods Corp.	——
4	Top Wealth Group Holding LimitedTWG	0%-0.01
5	NMHI - Nature's Miracle Holding Inc.	——
6	SKK Holdings Ltd Class A Ordinary SharesSKK	0%new
7	Samfine Creation Holdings Group Ltd. Class A Ordinary SharesSFHG	0%new
8	BYU - BAIYU Holdings, Inc.	——
9	Autonomix Medical Inc.AMIX	0%0
10	Cheetah Net Supply Chain Service Inc.CTNT	0.02%-0.01

1847 Holdings LLC

Location

Social

What share of all stock conversation is about EFSH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Apr 4

$EFSH is at risk of delisting, with some posters speculating that the company is intentionally delaying its delisting to create a pump.
The potential delist pump could lead to a significant price increase, with some posters warning that shorts will struggle to cover their positions in the low-liquidity OTC market.
The company's move to the OTC market is seen as a positive development by some posters, who believe it will allow the company to regain its listing and potentially create a new catalyst for growth.

Generated by AI

Sentiment

Of the messages about EFSH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	19.12% -49.23
Bearish	—	—	—	80.88% +49.23

Bullish· Feb 14

$EFSH has a small float of 16M, big cash of $27M, and is expected to pump to $1.
The 13g filing by L1 Capital, a frequent participant in large pumps, is a strong indication that $EFSH is about to be mega pumped.
$EFSH has reported strong revenue growth and profitability for fiscal year 2023 and nine months ended September 30, 2024, with a big cash balance of $27M.

Bearish· Apr 3

The company has a history of providing inaccurate financials and making up numbers to suit their goals.
The company's management team is accused of being "seasoned, professional con men" who have engaged in a "scheme" to deceive investors.
The stock is likely to be delisted due to its low price, and the company may be obligated to repay its debts immediately, which it cannot afford.

Generated by AI

Topics

Of the messages about EFSH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	1.25%
Announcements	—	—	—	33.75%
Controversies	—	—	—	65%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Announcements· Sep 1

Novo Nordisk is set to acquire Forma Therapeutics, expanding its presence in sickle cell disease and rare blood disorders.
The acquisition aims to enhance Novo Nordisk's capabilities in these areas, with potential implications for the company's future growth and market position.
The deal is expected to have a significant impact on the rare blood disorder treatment market, with Novo Nordisk poised to become a major player in this space.

Technical Analysis· Nov 22

$EFSH has been oversold on the 4HR chart, with a history of rebounding on a multiplier, and has strong sales growth, good margins, and positive FCF.
The stock has bullish indicators on the hourly chart, including tape/flow and 20D/50D MA/MACD, and has huge gaps to fill, with buyers detected all over the hourly indicators.
The TTM squeeze indicator shows that the climb up is just getting started, with a predicted slow upward trend leading to a major blast off, and a potential run up to $0.50 or higher.

Generated by AI

Community

Of the messages about EFSH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	24.45%
Newcomers	—	—	—	75.55%

Regulars· Sep 1

The company's short volume is 52.89% of its total volume, indicating significant bearish sentiment among investors.
The regulars are focused on the company's undervaluation, with one user arguing that the stock price should be $40 based on its revenue and float.
Another regular is concerned about the potential for naked shorting and the company's decision to do a reverse split, which they see as a way for the CEO and management to benefit at the expense of shareholders.

Newcomers· Sep 1

The 1-for-25 reverse stock split announced by 1847 Holdings LLC has sparked concerns about potential dilution and the company's intentions, with some speculating about the motivations behind the move.
Some users are calling for a tender offer to take shares away from alleged "abusers" and increase demand, while others believe the split will lead to a significant increase in share price.
There is concern about the potential for the stock price to drop significantly before the reverse split takes effect, and some users are warning about the risks of shorting the stock, citing the company's history of dilution and alleged crookedness towards shareholders.

Generated by AI

1847 Holdings

Social

Apr 4

Sentiment

Bullish· Feb 14

Bearish· Apr 3

Topics

Announcements· Sep 1

Technical Analysis· Nov 22

Community

Regulars· Sep 1

Newcomers· Sep 1

Also Discussed

1847 Holdings LLC

Company Information

Location

Social

Apr 4

Sentiment

Bullish· Feb 14

Bearish· Apr 3

Topics

Announcements· Sep 1

Technical Analysis· Nov 22

Community

Regulars· Sep 1

Newcomers· Sep 1

Also Discussed